Gabriel Adelsmayr

Dr. Gabriel Adelsmayr

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 June 2022 in Journal of Thoracic Imaging
Verified
Journal Article
Open access
JSJohannes Schmid
Johannes Schmid
ENEszter Nagy
Eszter Nagy
AKAnn-Katrin Kaufmann-Buehler
Ann-Katrin Kaufmann-Buehler
JSJakob Steiner
Jakob Steiner
MJMichael Janisch
Michael Janisch
GAGabriel Adelsmayr
Gabriel Adelsmayr
Purpose: Computed tomography pulmonary angiography (CT-PA) is frequently used in the diagnostic workup of pulmonary embolism (PE), even in highly radiosensitive patient populations. This study aims to assess CT-PA with reduced z-axis coverage (compared with a standard scan range covering the entire lung) for its sensitivity for detecting PE and its potential to reduce the radiation dose. Materials and Methods: We retrospectively analyzed 602 consecutive CT-PA scans with definite or possible PE reported. A reduced scan range was defined based on the topogram, where the cranial slice was set at the top of the aortic arch and the caudal slice at the top of the lower hemidiaphragm. Locations of emboli in relation to the reduced scan range were recorded. Results: We included 513 CT-PA scans with definite acute PE in statistical analysis. Patients’ median age was 66 (52 to 77) years, 46% were female. Median dose length product was 270.8 (111.3 to 503.9) mGy*cm. Comparing the original and reduced scan ranges, the mean scan length was significantly reduced by 48.0±8.6% (26.8±3.0 vs. 13.9±2.6 cm, P<0.001). Single emboli outside the reduced range in addition to emboli within were found in 15 scans (2.9%), while only 1 scan (0.2%) had an embolus outside the reduced range and none within it. The resulting sensitivity of CT-PA with reduced scan range was 99.81% (95% confidence interval: 98.74%-99.99%) for detecting any PE. Conclusion: A reduced scan length in CT-PA, as defined above, would substantially decrease radiation dose while maintaining diagnostic accuracy for detecting PE.

29 November 2020 in ESC Heart Failure
Verified
Journal Article
Open access
PDF file
GJGe Jin
Ge Jin
MMMartin Manninger
Martin Manninger
GAGabriel Adelsmayr
Gabriel Adelsmayr
MSMichael Schwarzl
Michael Schwarzl
AAAlessio Alogna
Alessio Alogna
FHFrank R. Heinzel
Frank R. Heinzel
Aims Atrial contractile dysfunction contributes to worse prognosis in hypertensive heart disease (HHD), but the role of cardiomyocyte dysfunction in atrial remodelling in HHD is not well understood. We investigated and compared cellular mechanisms of left (LA) and right atrial (RA) contractile dysfunction in pigs with HHD. Methods and results In vivo electrophysiological and magnetic resonance imaging studies were performed in control and pigs treated with 11‐deoxycorticosterone acetate (DOCA)/high‐salt/glucose diet (12 weeks) to induce HHD. HHD leads to significant atrial remodelling and loss of contractile function in LA and a similar trend in RA (magnetic resonance imaging). Atrial remodelling was associated with a higher inducibility of atrial fibrillation but unrelated to changes in atrial refractory period or fibrosis (histology). Reduced atrial function in DOCA pigs was related to reduced contraction amplitude of isolated LA (already at baseline) and RA myocytes (at higher frequencies) due to reduced intracellular Ca release (Fura 2‐AM, field stimulation). However, Ca regulation differed in LA and RA cardiomyocytes: LA cardiomyocytes showed reduced sarcoplasmic reticulum (SR) [Ca], whereas in RA, SR [Ca] was unchanged and SR Ca2+‐ATPase activity was increased. Sodium–calcium exchanger (NCX) activity was not significantly altered. We used ORM‐10103 (3 μM), a specific NCX inhibitor to improve Ca availability in LA and RA cardiomyocytes from DOCA pigs. Partial inhibition of NCX increased Ca2+ transient amplitude and SR Ca in LA, but not RA cells. Conclusions In this large animal model of HHD, atrial remodelling in sinus rhythm in vivo was related to differential LA and RA cardiomyocyte dysfunction and Ca signalling. Selective acute inhibition of NCX improved Ca release in diseased LA cardiomyocytes, suggesting a potential therapeutic approach to improve atrial inotropy in HHD.

8 August 2016 in BMC Medical Imaging
Verified
Journal Article
Open access
PDF file
GRGert Reiter
Gert Reiter
URUrsula Reiter
Ursula Reiter
GKGabor Kovacs
Gabor Kovacs
GAGabriel Adelsmayr
Gabriel Adelsmayr
AGAndreas Greiser
Andreas Greiser
MFMichael Fuchsjäger
Michael Fuchsjäger
In patients with pulmonary hypertension (PH), duration of vortical blood flow along the main pulmonary artery enables estimation of the mean pulmonary arterial pressure (mPAP) non-invasively. It remains to date not known, if this method is applicable in patients with pulmonary arterial hypertension (PAH) and abnormal aortic-to-pulmonary shunting. The present case analyzes the effect of a patent ductus arteriosus (PDA) on pulmonary artery flow patterns in PAH (mPAP from right heart catheterization, 75 mmHg). PH-associated vortical blood flow, which is typically observed rotating in a clockwise direction when viewed in right ventricular outflow tract orientation, was found nested in PDA left-to-right shunting. Even though rotating counter-clockwise, duration of vortical flow translated into correct non-invasive mPAP estimate. This case indicates that PH-associated vortex rotation is not restricted to clockwise direction, and that vortex-based estimation of elevated mPAP might also be feasible in patients with PAH and PDA.

Verified
Journal Article
Open access
PDF file
PGPaul Gressenberger
Paul Gressenberger
PJPhilipp Jud
Philipp Jud
GKGabor Kovacs
Gabor Kovacs
SKSonja Kreuzer
Sonja Kreuzer
HBHans-Peter Brezinsek
Hans-Peter Brezinsek
FMFlorentine C. Moazedi-Fürst
Florentine C. Moazedi-Fürst
Systemic sclerosis (SSc) is an intractable autoimmune disease characterized by vasculopathy and organ fibrosis. Autologous hematopoietic stem cell transplantation (AHSCT) should be considered for the treatment of selected patients with rapid progressive SSc at high risk of organ failure. It, however, remains elusive whether immunosuppressive therapies such as rituximab (RTX) are still necessary for such patients after AHSCT, especially in those with bad outcomes. In the present report, a 43-year-old man with diffuse cutaneous SSc received AHSCT. Despite AHSCT, SSc further progressed with progressive symptomatic heart failure with newly developed concomitant mitral and tricuspid valve insufficiency, thus the patient started on RTX 8 months after AHSCT. Shortly after initiation of RTX, clinical symptoms and organ functions ameliorated subsequently. Heart valve regurgitations were reversible after initiation of RTX treatment. Currently, the patient remains in a stable condition with significant improvement of clinical symptoms and organ functions. Reporting about therapies after AHSCT in SSc is a very important issue, as randomized controlled trials are lacking, and therefore this report adds to evidence that RTX can be considered as a treatment option in patients with SSc that do not respond to AHSCT.

1 January 2024 in Digital Health
Verified
Journal Article
Open access
GAGabriel Adelsmayr
Gabriel Adelsmayr
MJMichael Janisch
Michael Janisch
MPMaximilian Pohl
Maximilian Pohl
MFMichael Fuchsjäger
Michael Fuchsjäger
HSHelmut Schoellnast
Helmut Schoellnast
Aim: This study aimed to evaluate perceptions and expectations towards artificial intelligence (AI) applications in diagnostic radiology among radiologists across academic, non-academic and private practice settings in the Federal State of Styria, Austria. It also sought to determine how participant's characteristics and AI-specific knowledge might influence these views. Methods: An online quantitative survey comprising 20 multiple-choice questions in German language was distributed via email to radiologists in outpatient and hospital settings throughout Styria in 2024. Results: Out of 149 radiologists contacted, 66 responded. Of these, 75.4% reported having basic knowledge of AI, 13.8% indicated good to very good knowledge and only 10.8% had minimal AI-specific knowledge. The majority (84.4%) expressed willingness to use certified AI software in diagnostics. About half of the respondents (50.8%) believed that AI would not fully replace radiologists in the next 10–15 years, although 46.0% anticipated partial replacement. Additionally, 87.7% did not foresee a decrease in professional income due to AI integration. 64.6% anticipated improvement in diagnostic tasks through AI, with this expectation being significantly linked to an academic career (χ2 = 8.97, p = 0.01). However, opinions varied on AI's potential to outperform radiologists in diagnostics in the near future. There was no statistically significant relationship between participant's AI-specific knowledge and perceptions and expectations towards AI. Conclusion: The study reveals a generally positive attitude towards AI among radiologists, with uncertainties about its future performance compared to human radiologists. Although AI is anticipated to positively influence workload without reducing income, there may be a discrepancy between these expectations and actual outcomes.

1 August 2021 in European Journal of Radiology
Verified
Journal Article
Closed access
EJElmar Janek
Elmar Janek
DEDominik Edl
Dominik Edl
ATAdrian Taflinski
Adrian Taflinski
ETEmina Talakic
Emina Talakic
GAGabriel Adelsmayr
Gabriel Adelsmayr
HSHelmut Schöllnast
Helmut Schöllnast